Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | RXRA | P19793 | 11/20 | 0.50 |
| ▸ | RXRG | P48443 | 7/20 | 0.49 |
| ▸ | RXRB | P28702 | 8/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.32 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.32 |
| ▸ | CYP2C19 | P33261 | 2/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.31 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.30 |
| ▸ | CD69 | Q07108 | 1/20 | 0.30 |
| ▸ | IDO1 | P14902 | 1/20 | 0.30 |
| ▸ | TDO2 | P48775 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29403030 | 1.00 | RXRA (0.50) | RXRARXRGRXRBPTGS1PTGS2 | |
| SCHEMBL29528253 | 0.90 | RXRA (0.52) | RXRARXRGRXRBELANECD69 | |
| SCHEMBL21518796 | 0.86 | RXRA (0.48) | RXRARXRGRXRBPTGS1PTGS2 | |
| SCHEMBL28665083 | 0.85 | RXRA (0.48) | RXRARXRGRXRBCYP2C19 | |
| SCHEMBL1225260 | 0.80 | RXRA (0.47) | RXRARXRGRXRB | |
| SCHEMBL29374183 | 0.78 | RXRA (0.63) | RXRARXRGRXRBPTGS1PTGS2 | |
| SCHEMBL112943 | 0.78 | RXRA (0.63) | RXRARXRGRXRBPTGS1PTGS2 | |
| SCHEMBL3633427 | 0.77 | RXRA (0.65) | RXRARXRGRXRB | |
| Acetic Acid SCHEMBL8421363 | 0.75 | RXRA (0.54) | RXRARXRGRXRBCYP2C19CYP1A2 | |
| SCHEMBL8012309 | 0.75 | RXRA (0.50) | RXRARXRGRXRBCYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 306 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-113056547-A | Jasmine alcohol | 西姆莱斯有限公司 | 2021-06-29 | — | — | CN | claimed |
| US-12630783-B2 | Muguet type fragrance compounds | SYMRISE AG (DE) | 2026-05-19 | — | — | US | disclosed |
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | SYMRISE AG (DE) | 2026-03-17 | — | — | US | disclosed |
| EP-3826986-B1 | NOVEL ODORANTS HAVING ROSE ODOUR | SYMRISE AG (DE) | 2026-03-04 | — | — | EP | disclosed |
| US-12545851-B2 | Fragrances with note of lily of the valley | SYMRISE AG (DE) | 2026-02-10 | — | — | US | disclosed |
| EP-4045490-B1 | NEW AROMATIC MONOTHIOKETALS AS FRAGRANCES | SYMRISE AG (DE) | 2025-12-03 | — | — | EP | disclosed |
| US-12441953-B2 | Isomer mixtures of unsaturated macrocyclic musk compounds | SYMRISE AG (DE) | 2025-10-14 | — | — | US | disclosed |
| EP-4624559-A2 | ISOMER MIXTURES OF UNSATURATED MACROCYCLIC MUSK COMPOUNDS | Symrise AG (DE) | 2025-10-01 | — | — | EP | disclosed |
| EP-3898910-B1 | ALICYCLIC MUSK FRAGRANCE COMPOUNDS | SYMRISE AG (DE) | 2025-09-03 | — | — | EP | disclosed |
| EP-3880777-B1 | PERFUMING INGREDIENTS WITH LILY OF THE VALLEY NOTE | SYMRISE AG (DE) | 2025-06-25 | — | — | EP | disclosed |
| EP-1310240-A1 | 6-Alkylindane-1-ones as perfuming agents | HAARMANN & REIMER GMBH (DE) | 2003-05-14 | — | — | EP | disclosed |
| WO-2003038019-A1 | MIXTURES FOR USE AS MUSK FRAGRANCE | SYMRISE GMBH & CO. KG (DE) | 2003-05-08 | — | — | WO | disclosed |
| WO-2003037841-A1 | MIXTURES FOR USE AS MUSK FRAGRANCE | SYMRISE GMBH & CO. KG (DE) | 2003-05-08 | — | — | WO | disclosed |
| EP-1285907-A2 | Compositions for the controlled release of an aldehyde together with two carboxylic acids | HAARMANN & REIMER GMBH (DE) | 2003-02-26 | — | — | EP | disclosed |
| EP-1285906-A2 | Compositions for the controlled release of an aldehyde or ketone, an alcohol and a carboxylic acid | HAARMANN & REIMER GMBH (DE) | 2003-02-26 | — | — | EP | disclosed |
| EP-1220850-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2002-07-10 | — | — | EP | disclosed |
| EP-1215189-A1 | Process for the preparation of isolongifolanol | HAARMANN & REIMER GMBH (DE) | 2002-06-19 | — | — | EP | disclosed |
| EP-1111029-A2 | Perfume compositions containing 4,8-dimethyl-3,7-nonadien-2-one | HAARMANN & REIMER GMBH (DE) | 2001-06-27 | — | — | EP | disclosed |
| WO-2001023373-A2 | 1,4-DIOXACYCLOALKANE-2-ONE AND 1,4-DIOXACYCLOALKENE-2-ONE | HAARMANN & REIMER GMBH (DE) | 2001-04-05 | — | — | WO | disclosed |
| EP-1067126-A2 | Tetracyclic acetals | HAARMANN & REIMER GMBH (DE) | 2001-01-10 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12577495-B2 | Fragrance mixtures containing 1-(4,4-dimethylcyclohexen-1-yl) ethanon | ALG3, FAAH, FAAH2 | RXRA 812/4885RXRG 1457/4885RXRB 687/4885 |
| US-12630783-B2 | Muguet type fragrance compounds | MGAT1, RFT1, CPT1A | RXRA 1951/4885RXRG 2383/4885RXRB 1700/4885 |
| US-12545851-B2 | Fragrances with note of lily of the valley | TRPA1, CDY1; CDY1B, TMEM109 | RXRA 2278/4885RXRG 2509/4885RXRB 1933/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.